566 related articles for article (PubMed ID: 20527377)
1. [Obesity--insulin resistance--type 2 diabetes mellitus].
Małecki MT
Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S561-6. PubMed ID: 20527377
[TBL] [Abstract][Full Text] [Related]
2. Advances in adipokines.
Sahin-Efe A; Katsikeris F; Mantzoros CS
Metabolism; 2012 Dec; 61(12):1659-65. PubMed ID: 23021039
[No Abstract] [Full Text] [Related]
3. [The role of the fat tissue and its hormones in the mechanisms of insulin resistance and the development of type 2 diabetes mellitus].
Klebanova EM; Balabolkin MI; Kreminskaia VM
Klin Med (Mosk); 2007; 85(7):20-7. PubMed ID: 17882804
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
5. Adipose tissue dysfunction and metabolic disorders: Is it possible to predict who will develop type 2 diabetes mellitus? Role of markErs in the progreSsion of dIabeteS in obese paTIeNts (The RESISTIN trial).
Derosa G; Catena G; Gaudio G; D'Angelo A; Maffioli P
Cytokine; 2020 Mar; 127():154947. PubMed ID: 31811995
[TBL] [Abstract][Full Text] [Related]
6. Adipotoxicity and the insulin resistance syndrome.
Anderwald C; Roden M
Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
Goralski KB; Sinal CJ
Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects associated with adipose tissue distribution.
Zahorska-Markiewicz B
Adv Med Sci; 2006; 51():111-4. PubMed ID: 17357288
[TBL] [Abstract][Full Text] [Related]
9. Review article: adipocytokines and insulin resistance.
Vettor R; Milan G; Rossato M; Federspil G
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():3-10. PubMed ID: 16225463
[TBL] [Abstract][Full Text] [Related]
10. [Resistin: a pathogenic factor or a biomarker of metabolic disorders and inflammation?].
Karbowska A; Boratyńska M; Klinger M
Postepy Hig Med Dosw (Online); 2009 Oct; 63():485-91. PubMed ID: 19940327
[TBL] [Abstract][Full Text] [Related]
11. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
Dyck DJ; Heigenhauser GJ; Bruce CR
Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance as the core defect in type 2 diabetes mellitus.
Goldstein BJ
Am J Cardiol; 2002 Sep; 90(5A):3G-10G. PubMed ID: 12231073
[TBL] [Abstract][Full Text] [Related]
13. [Avandia and avandamet in the treatment of patients with diabetes mellitus type 2: effects on secretion of some fat tissue hormones].
Balabolkin MI; Mamaeva GG; Klebanova EM; Kuzin AG; Tel'nova ME; Kreminskaia VM
Ter Arkh; 2008; 80(10):21-6. PubMed ID: 19105408
[TBL] [Abstract][Full Text] [Related]
14. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
15. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?
Gabriely I; Ma XH; Yang XM; Atzmon G; Rajala MW; Berg AH; Scherer P; Rossetti L; Barzilai N
Diabetes; 2002 Oct; 51(10):2951-8. PubMed ID: 12351432
[TBL] [Abstract][Full Text] [Related]
16. Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro.
Lappas M; Yee K; Permezel M; Rice GE
Endocrinology; 2005 Mar; 146(3):1491-7. PubMed ID: 15564333
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance in type 2 diabetes -- role of the adipokines.
Arner P
Curr Mol Med; 2005 May; 5(3):333-9. PubMed ID: 15892652
[TBL] [Abstract][Full Text] [Related]
18. Adipose tissue as an endocrine organ.
Galic S; Oakhill JS; Steinberg GR
Mol Cell Endocrinol; 2010 Mar; 316(2):129-39. PubMed ID: 19723556
[TBL] [Abstract][Full Text] [Related]
19. The effects of beta(3)-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-alpha expressions in adipose tissues of obese diabetic KKAy mice.
Fu L; Isobe K; Zeng Q; Suzukawa K; Takekoshi K; Kawakami Y
Eur J Pharmacol; 2008 Apr; 584(1):202-6. PubMed ID: 18304529
[TBL] [Abstract][Full Text] [Related]
20. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
You T; Yang R; Lyles MF; Gong D; Nicklas BJ
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
